Source: ERS Lung Science Conference 2017



Rating:

Share or cite this content

Citations should be made in the following way:
Xiang Zheng (Bad Nauheim, Germany). Re-education of tumor-associated macrophages by modulating histone deacetylases in lung cancer. ERS Lung Science Conference 2017

Member's Comments

No comment yet.

Related content which might interest you: LSC - 2017 - Re-education of tumor-associated macrophages by modulating histone deacetylases in lung cancer Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 The role of histone deacetylase 9 in the imbalance of Th17/Treg in bronchial asthma Source: Annual Congress 2012 - Mechanisms of asthma Year: 2012 Histone deacetylases (HDACs) and lung disease Source: Annual Congress 2011 - Why is epigenetics important for lung disease? Year: 2011 Histone deacetylase inhibition significantly augments human mesothelioma cellular response to chemotherapeutic agents Source: Eur Respir J 2001; 18: Suppl. 33, 396s Year: 2001 LSC Abstract – Histone deacetylase 7 mediated metabolic remodeling: A new crosslink between pulmonary hypertension and cancer Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Histone deacetylase inhibitor panobinostat reduces hypoxia-related cisplatin resistance in NSCLC cells by HDAC-mediated Hifalpha destabilization Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Histone acetylation and deacetylation: importance in inflammatory lung diseases Source: Eur Respir J 2005; 25: 552-563 Year: 2005 Comparison of anticancer effects of a novel histone deacetylase (HDAC) inhibitor CG200745 and SAHA in non-small lung cancer cells Source: International Congress 2019 – Diagnostic procedures and biology of lung cancer Year: 2019 Regulation of eosinophil and neutrophil apoptosis by histone hyperacetylation Source: Eur Respir J 2003; 22: Suppl. 45, 572s Year: 2003 Decreased histone deacetylase activity in COPD Source: Annual Congress 2008 - Epigenetic modifications in lung disease Year: 2008 DNA methylation and histone modifications of susceptibility in COPD and lung cancer Source: Annual Congress 2011 - Why is epigenetics important for lung disease? Year: 2011 Histone demethylation and acetylation are involved in the epigenetic regulation of epithelial-mesenchymal transition (EMT) Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 Histone deacetylase activity and gene expression in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 316s Year: 2001 Steroids and histone deacetylase in ventilation-induced gene transcription Source: Eur Respir J 2007; 30: 865-877 Year: 2007 Effect of cigarette smoke extract (CSE) on histone acetylation of lung fibroblasts in vitro compared to histone acetylation in patients with lung emphysema Source: Eur Respir J 2006; 28: Suppl. 50, 583s Year: 2006 Aberrant expression and activity of histone deacetylases in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice Source: Eur Respir J 2014; 43: 1448-1458 Year: 2014 Global histone H3 lysine 4 (H3K4) dimethylation is an important prognostic factor in lung cancer Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Histone deacetylase activity is reduced in COPD. Modulation by theophylline Source: Eur Respir J 2003; 22: Suppl. 45, 4s Year: 2003 Effect of cigarette smoking on histone deacetylase activity in alveolar macrophages Source: Eur Respir J 2002; 20: Suppl. 38, 416s Year: 2002